What are the most effective treatments for post‑viral cough in an adult?

Treatment of Post-Viral Cough in Adults

For post-viral cough (lasting 3-8 weeks after upper respiratory infection), inhaled ipratropium bromide 2-3 puffs four times daily is the first-line pharmacologic treatment with the strongest evidence for symptom reduction, followed by inhaled corticosteroids if quality of life remains impaired. 1

Understanding Post-Viral Cough

Post-viral cough is defined as cough persisting for 3-8 weeks following an acute respiratory infection 2. The pathophysiology involves ongoing airway inflammation, bronchial hyperresponsiveness, mucus hypersecretion, impaired mucociliary clearance, and heightened cough-reflex sensitivity—not ongoing infection 1, 3. This is a self-limited condition in most cases, but it can significantly impair quality of life 4.

Evidence-Based Treatment Algorithm

First-Line: Supportive Care (Weeks 1-3)

• Honey and lemon can be recommended as the simplest and cheapest initial advice, working through central modulation of the cough reflex 1.
• Simple voluntary cough suppression may be sufficient to reduce cough frequency 1.
• Adequate hydration, rest, and reassurance are appropriate initial measures 3.

Second-Line: Inhaled Ipratropium Bromide

• Inhaled ipratropium bromide 2-3 puffs (17-34 mcg per puff) four times daily has the strongest evidence from controlled trials for attenuating post-infectious cough 1, 3, 5.
• Clinical response is typically seen within 1-2 weeks 1, 3.
• This should be initiated when cough persists beyond 1-2 weeks and adversely affects quality of life 3.

Third-Line: Inhaled Corticosteroids

• Inhaled corticosteroids (fluticasone 220 mcg or budesonide 360 mcg twice daily) should be added if cough persists despite ipratropium and continues to impair quality of life 1, 3.
• The mechanism involves suppression of airway inflammation and bronchial hyperresponsiveness 1.
• Allow up to 8 weeks for full therapeutic response 1, 3.

Fourth-Line: Oral Corticosteroids (Severe Cases Only)

• Oral prednisone 30-40 mg daily for 5-10 days is reserved exclusively for severe paroxysms that significantly impair quality of life 1, 3.
• This should only be prescribed after ruling out upper airway cough syndrome, asthma, and gastroesophageal reflux disease 1, 3.

Fifth-Line: Central Antitussives (When Other Measures Fail)

• Dextromethorphan 60 mg provides maximum cough reflex suppression and is preferred over codeine due to fewer side effects 1.
• Codeine and pholcodine have no greater efficacy than dextromethorphan but carry a much greater adverse side effect profile including drowsiness, nausea, constipation, and physical dependence 1.
• First-generation sedating antihistamines may be suitable specifically for nocturnal cough 1.
• Central-acting antitussives should be considered only when other treatments fail 1.

Critical: What NOT to Do

• Antibiotics are explicitly contraindicated for post-viral cough unless there is confirmed bacterial sinusitis or early pertussis infection 1, 3, 5.
• Antibiotics provide no benefit, contribute to antimicrobial resistance, and cause unnecessary adverse effects 1, 3.
• The cause is viral-induced airway inflammation, not bacterial infection 3, 5.

When to Reassess and Reclassify

• If cough persists beyond 8 weeks, it must be reclassified as chronic cough and systematically evaluated for upper airway cough syndrome, asthma, and gastroesophageal reflux disease 1, 3, 5.
• Chest radiography and spirometry become mandatory at this point 2.

Special Consideration: Pertussis

• Consider pertussis when cough lasts ≥2 weeks with paroxysms, post-tussive vomiting, or inspiratory whooping sound 1, 3, 5.
• Nasopharyngeal culture is the gold standard for diagnosis 1.
• Macrolide antibiotics are indicated for confirmed pertussis, with 5-day isolation from treatment start 1.

Common Pitfalls to Avoid

• Failing to recognize when post-infectious cough has persisted beyond 8 weeks, which requires reclassification as chronic cough and different evaluation 1, 3.
• Inappropriate antibiotic use for non-bacterial causes of post-infectious cough 1, 3.
• Overlooking underlying conditions (asthma, upper airway cough syndrome, GERD) that may contribute to persistent cough 1.
• Jumping to prednisone for mild post-infectious cough when it should be reserved for severe cases that have failed other therapies 3.
• Assuming that colored or green sputum indicates bacterial infection—most short-term coughs are viral even when producing colored phlegm 3.

Monitoring and Follow-Up

• Patients should be followed up within 4-6 weeks after initial evaluation 1.
• Treatment response should be assessed using validated cough severity tools 1.
• If cough persists beyond 8 weeks, further evaluation for chronic cough causes is warranted 1, 3.

Red Flags Requiring Immediate Re-evaluation

• Development of fever in a patient with prolonged cough mandates reassessment for pneumonia 5.
• Hemoptysis, weight loss, night sweats, or other constitutional symptoms require chest X-ray and systematic evaluation 5.
• Crackles, clubbing, or other concerning physical exam findings warrant advanced evaluation including high-resolution CT chest and possibly bronchoscopy 1.